Folgen
PATRICIO LOPEZ -JARAMILLO
PATRICIO LOPEZ -JARAMILLO
General Rector, Scientific Director Masira, UDES,Bucaramanga,Colombia. Vist Prof, UTE,Ecuador
Bestätigte E-Mail-Adresse bei udes.edu.co
Titel
Zitiert von
Zitiert von
Jahr
Heart disease and stroke statistics—2013 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
circulation 127 (1), e6-e245, 2013
77696*2013
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ...
The Lancet 376 (9735), 112-123, 2010
45702010
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
26812019
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries
CK Chow, KK Teo, S Rangarajan, S Islam, R Gupta, A Avezum, ...
Jama 310 (9), 959-968, 2013
2618*2013
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
26172017
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ...
The lancet 388 (10046), 761-775, 2016
24442016
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
2234*2021
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
DP Leong, KK Teo, S Rangarajan, P Lopez-Jaramillo, A Avezum, ...
The lancet 386 (9990), 266-273, 2015
19892015
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort …
S Yusuf, P Joseph, S Rangarajan, S Islam, A Mente, P Hystad, M Brauer, ...
The Lancet 395 (10226), 795-808, 2020
17772020
The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study
SA Lear, W Hu, S Rangarajan, D Gasevic, D Leong, R Iqbal, A Casanova, ...
The Lancet 390 (10113), 2643-2654, 2017
14932017
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
M Dehghan, A Mente, X Zhang, S Swaminathan, W Li, V Mohan, R Iqbal, ...
The Lancet 390 (10107), 2050-2062, 2017
12932017
Cardiovascular risk and events in 17 low-, middle-, and high-income countries
S Yusuf, S Rangarajan, K Teo, S Islam, W Li, L Liu, J Bo, Q Lou, F Lu, ...
New England Journal of Medicine 371 (9), 818-827, 2014
11762014
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective …
S Yusuf, S Islam, CK Chow, S Rangarajan, G Dagenais, R Diaz, R Gupta, ...
The Lancet 378 (9798), 1231-1243, 2011
11212011
Urinary sodium and potassium excretion, mortality, and cardiovascular events
M O'Donnell, A Mente, S Rangarajan, MJ McQueen, X Wang, L Liu, H Yan, ...
New England Journal of Medicine 371 (7), 612-623, 2014
10962014
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
10722016
Association of urinary sodium and potassium excretion with blood pressure
A Mente, MJ O'Donnell, S Rangarajan, MJ McQueen, P Poirier, ...
New england journal of medicine 371 (7), 601-611, 2014
10362014
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
MH Olsen, SY Angell, S Asma, P Boutouyrie, D Burger, JA Chirinos, ...
The Lancet 388 (10060), 2665-2712, 2016
10172016
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
10012018
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
8252016
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
GR Dagenais, DP Leong, S Rangarajan, F Lanas, P Lopez-Jaramillo, ...
The Lancet 395 (10226), 785-794, 2020
7342020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20